Hemolytic uremic syndrome induced by gemcitabine. A poorly recognized complication?;Syndrome hémolytique et urémique induit par la gemcitabine. Une complication méconnue?

Revue Medicale de Liege

Volumn 67, Issue 12, 2012, Pages 644-648

  Graas, M P ^a   Houbiers, G ^b   Demolin, G ^b   Stultiens, A A ^a   Focan, C ^a  

^a CHC Saint Joseph   (Belgium)

^b CHC Saint Joseph   (Belgium)

Author keywords

Gemcitabine; Hemolytic uremic syndrome

Indexed keywords

GEMCITABINE;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CLINICAL ARTICLE; DIALYSIS; DRUG INFUSION; FEMALE; HEMOLYTIC ANEMIA; HEMOLYTIC UREMIC SYNDROME; HUMAN; KIDNEY FAILURE; KIDNEY FUNCTION; LONG TERM CARE; MALE; PALLIATIVE THERAPY;

AGED; ANTIMETABOLITES, ANTINEOPLASTIC; DEOXYCYTIDINE; DISEASE PROGRESSION; FEMALE; HEMOLYTIC-UREMIC SYNDROME; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; RENAL DIALYSIS; RENAL INSUFFICIENCY; TIME FACTORS;

EID: 84872298074     PISSN: 0370629X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Veyradier A, Loirat C, Girma JP, et al.- Purpura thrombotique thrombocytopénique par deficit héréditaire en ADAMTS13 (syndrome d'Upshaw-Schulman): actualités et perspectives. Hématologie, 2005, 5, 321-34. (Pubitemid 41784326)
2. Zheng XL, Sadler JE.- Pathogenesis of thrombotic microangiopathies. Annu Rev Pathol, 2008, 3, 249-277.
3. Nogue Kamdje A, Brasseur E, Fournier L, D'Orio V.-Syndrome hémolytique et urémique : à propos d'une présentation atypique. Rev Med Liège, 2010, 12, 676-680.
4. George JN, Leung LLK, Landaw SA.- Causes of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome in adults. UpToDate, 2010, 39. (hppt://www.uptodate.com/contents/.)
5. Kaplan AA, George JN, Leung LLK, Landaw SA.- Treatment of thrombotic thrombocytopenic purpura- hemolytic uremic syndrome in adults. UpToDate, 2010, 22. (http://www.uptodate.com/contents/.)
6. Fung MC, Stomiolo AM, Nguyen B, et al.- A review of hemolytic uremic syndrome in patients treated with gemcitabine therapy. Cancer, 1999, 9, 2023-2032. (Pubitemid 29202779)
7. Desramé J, Duvic C, Bredin C, et al.- Syndrome hémolytique et urémique secondaire à la gemcitabine : à propos de six observations et revue de la littérature. Rev Med Interne, 2005, 3, 179-188.
8. Desramé J, Duvic C, Béchade D, et al.- La fréquence du syndrome hémolytique et urémique secondaire à la gemcitabine est-elle sous-estimée ? Gastroentérologie Clinique et Biologique, 2006, 2, 332-334.
9. Arnadottir M, Benediktsson T, Hrafnkelsson H.- The cumulative incidence of gemcitabine-induced thrombotic microangiopathy. Acta Oncologica, 2007, 46, 545-546. (Pubitemid 46752259)
10. Finkenwirth P, Schick D, Horger MS, et al.- Thrombotic microangiopathy under an effective treatment with gemcitabine. Gastroenterol, 2009, 3, 288-291.
11. Humphreys BD, Sharman JP, Henderson JM, et al.- Gemcitabine-associated thrombotic microangiopathy. Cancer, 2004, 12, 2664-2670.
12. Glezerman I, Kris MG, Miller V, et al.- Gemcitabine nephrotoxicity and hemolytic uremic syndrome : report of 29 cases from a single institution. Clin Nephrol, 2009, 2, 130-139.
13. Gore EM, Jones BS, Marques MB.- Is therapeutic plasma exchange indicated for patients with gemcitabine-induced hemolytic uremic syndrome ? J Clin Apher, 2009, 5, 209-214.
14. Muller S, Schutt P, Bojko P, et al.- Hemolytic uremic syndrome following prolonged gemcitabine therapy : report of four cases from a single institution. Ann Hematology, 2005, 2, 110-114. (Pubitemid 40089767)